TMDX
TMDX
NASDAQ · Health Care

Transmedics Group Inc

$83.89
+3.68 (+4.59%)
As of Aug 9, 9:53 PM ET ·
Financial Highlights (FY 2026)
Revenue
514.06M
Net Income
161.56M
Gross Margin
59.9%
Profit Margin
31.4%
Rev Growth
+86.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 514.06M 275.76M 2.67B 2.60B
Gross Profit 308.03M 165.23M 1.10B 1.07B
Operating Income 92.17M 44.50M 215.76M 258.19M
Net Income 161.56M 78.00M 176.17M 221.55M
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Rev Growth +86.4% +86.4% -8.6% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 750.65M 750.65M 1.93B 1.88B
Total Equity 693.05M 693.05M 2.11B 1.74B
D/E Ratio 1.08 1.08 0.92 1.08
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 92.36M 47.06M 309.48M 247.18M
Free Cash Flow 251.22M 206.55M